首页> 外国专利> Pharmaceutical Composition of GPR40 agonist Compounds; method; Prevention and treatment; and use for treating cognitive disorders, osteoporosis, inflammatory recurrent disorders, diabetes, hyperglycemia, obesity, glucose intolerance, insulin resistance, hyperinsulinemia and hipercolesterolem Ia, among other diseases.

Pharmaceutical Composition of GPR40 agonist Compounds; method; Prevention and treatment; and use for treating cognitive disorders, osteoporosis, inflammatory recurrent disorders, diabetes, hyperglycemia, obesity, glucose intolerance, insulin resistance, hyperinsulinemia and hipercolesterolem Ia, among other diseases.

机译:GPR40激动剂化合物的药物成分;方法;预防和治疗;以及用于治疗认知疾病,骨质疏松症,炎症复发性疾病,糖尿病,高血糖症,肥胖症,葡萄糖耐受不良,胰岛素抵抗,高胰岛素血症和hiercolesterolem Ia等疾病。

摘要

Iminodifenilo GPR40 agonists Compounds, Pharmaceutical Composition and use for treating cognitive disorders, osteoporosis, inflammatory recurrent disorders, diabetes, hyperglycemia, obesity, glucose intolerance, insulin resistance, hyperinsulinemia, among other diseases.
机译:Iminodifenilo GPR40激动剂化合物,药物组合物和用途,用于治疗认知障碍,骨质疏松,炎症复发性疾病,糖尿病,高血糖症,肥胖症,葡萄糖耐量,胰岛素抵抗,高胰岛素血症以及其他疾病。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号